close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Health Panel

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Health Profile

Enter health info to personalize results.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Eytan Stein

location-icon

New York, NY

LOCATION OF PRACTICE
Memorial Sloan Kettering Cancer Center
MEDICAL Specialty:

Myelodysplastic Syndrome (mds)



NPI Number
1114100047
ABOUT

Eytan M. Stein, MD, is a hematologist-oncologist at who specializes in caring for people with acute and chronic leukemias, myelodysplastic syndromes, and myeloproliferative neoplasms. Dr. Stein is also an active clinical researcher who develops new and innovative approaches to treating acute myeloid leukemia (AML). Dr. Stein also works as an early drug development specialist

Dr. Eytan Stein profile image

Published Articles

Hypomethylating agents plus venetoclax versus intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia.- 2026 Apr 2
Expert perspectives on Myalgic encephalomyelitis/chronic fatigue syndrome - Insights from the 3(rd) International Conference of the Charité Fatigue Center.- 2026 Mar 25
Pre-operative MRI Bone Texture is Associated with Complications After Spine Fusion.- 2026 Mar 26
Managing Conflicting Prognostic Communication Preferences in Pediatric Oncology.- 2026 Mar 2
Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics.- 2026 May
Supplementation with mixed nuts does not improve inflammatory biomarkers or dietary inflammatory potential in post-myocardial infarction: a secondary analysis of the DICA-NUTS trial.- 2026 Feb 11
ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure.- 2026 Apr 1
Focal Transcranial Magnetic Stimulation of the Rat Anterior Cingulate Cortex Inhibits Incubation of Opioid Craving after Voluntary Abstinence.- 2026 Mar 6
Gatherings in Esophagology: Innovations and Future Directions in the Diagnosis and Management of Reflux Disease.- 2026 Mar
Bridging Functions and Values: Advancing Wetland Ecosystem Service Assessment Through Use of a Service Capacity Index.- 2026

Clinical Trials

A Study of E7820 in People With Bone Marrow (Myeloid) Cancers
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Study of REM-422 in Patients With AML or Higher Risk MDS
A Study of Revumenib and Mezigdomide in People With Leukemia
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

My Patient Resources

Other Specialists treating Myelodysplastic Syndrome (MDS) in New York, NY

See All Doctors

Dr. Jun Choi

Specialty: Hematology/Oncology

My Resources
location-icon

NYU Langone Perlmutter Cancer Center

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider